Elevance Health
No price chart data available for 1D timeframe.
Rating
Why Price Moved
Shares are trading higher on optimism over Medicai...
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to v...
Latest News
14 hours ago · zacks.com
Can Medicaid Rate Improvements Drive Elevance's 2027 Margin Recovery?ELV eyes a Medicaid margin recovery in 2027 as reimbursement rates improve, but elevated medical costs and uneven state adjustments remain key hurdles.
3 days ago · marketbeat.com
Elevance Health Targets 12% Earnings Growth in 2027 as Insurance Margins RecoverElevance Health NYSE: ELV expects adjusted earnings per share to grow at least 12% in 2027 from its recently increased 2026 baseline of at least $26.75, Chief Financial Officer Mark Kaye said at a UBS conference.
18 days ago · zacks.com
Elevance Health (ELV) Is Up 2.73% in One Week: What You Should KnowDoes Elevance Health (ELV) have what it takes to be a top stock pick for momentum investors? Let's find out.
21 days ago · gurufocus.com
ELV Fairly Valued by DCF at $418On October 27, 2026, we delve into the DCF analysis for Elevance Health Inc (ELV), a company that has shown notable price performance over the past year, with a
22 days ago · zacks.com
Implied Volatility Surging for Elevance Health Stock OptionsInvestors need to pay close attention to ELV stock based on the movements in the options market lately.
26 days ago · seekingalpha.com
Elevance Health: Better Results, But Not Enough To BuyElevance Health raised its 2026 adjusted EPS guidance to at least $29, but the sustainability of its earnings recovery remains uncertain. Third-quarter adjusted EPS rose 15.9%, while nine-month operating gain declined 25.7%, highlighting the gap between improving earnings and underlying profitability. Health Benefits margins remain under pressure, particularly in Medicaid, despite improving medical cost trends and stronger quarterly results.
26 days ago · fool.com
Elevance: 3 Key Takeaways for Long-Term InvestorsElevance raised its 2026 earnings baseline to at least $26.75 per share. Carelon's cancer program reduced avoidable inpatient admissions by 15%.
26 days ago · zacks.com
Elevance Health, Inc. (ELV) Hits Fresh High: Is There Still Room to Run?Elevance Health (ELV) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
27 days ago · seekingalpha.com
Elevance Health, Inc. (ELV) Q3 2026 Earnings Call TranscriptElevance Health, Inc. (ELV) Q3 2026 Earnings Call Transcript
27 days ago · zacks.com
ELV Beats Q3 Earnings Estimates on Carelon Strength, Raises 2026 OutlookElevance Health beats Q3 EPS estimate by 50% as Carelon grows despite declining medical membership, and lifts its 2026 underlying earnings baseline to $26.75.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove ELV